Ilya V. Tsimafeyeu
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society.
Journal: Exploration of targeted anti-tumor therapy
Published: April 13, 2026
Distinct pathways of disease progression with dual checkpoint blockade versus immunotargeted therapy in metastatic renal cell carcinoma.
Journal: Urologic oncology
Published: September 01, 2025
Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?
Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?
Journal: BJU international
Published: August 29, 2025
Prevalence of erectile dysfunction and its association with age in patients with metastatic renal cell carcinoma: results from a prospective multicenter study.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: June 28, 2025
Expression of Platelet-Derived Growth Factor Alpha and Beta Receptors in Primary Tumor Cells of Patients with Renal Cell Carcinoma.
Journal: Urology research & practice
Published: May 28, 2025
Nivolumab Combined with Chemotherapy in FGFR2 and PD-L1 Co-Expressing Metastatic Gastric Cancer: A Prospective Phase 2 NIVOFGFR2 Study.
Journal: Journal of gastrointestinal cancer
Published: January 06, 2025
Increase in workload among genitourinary oncologists drives burnout: Insights from the BUCARE survey.
Journal: Urologic oncology
Published: December 22, 2024
Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy.
Journal: Exploration of targeted anti-tumor therapy
Published: December 10, 2024
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma.
Journal: Exploration of targeted anti-tumor therapy
Published: December 04, 2024
Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study.
Journal: Current oncology (Toronto, Ont.)
Published: November 19, 2024
Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real-World, Ambispective RAVE-Bladder Study.
Journal: Cancer medicine
Published: October 10, 2024
A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models.
Journal: Immuno-oncology technology
Published: September 18, 2024
Last Updated: 09/26/2026